FIELD: chemistry.
SUBSTANCE: invention relates to ethyl ester of 2-(adamantan-1-yl)-3-bromo-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-6-carboxylic acid 3,
having a pronounced inhibitory effect action on coronavirus SARS-CoV-2, strain hCoV-19/Russia/Vologda-171613-1208/2020.
EFFECT: obtaining a novel compound which can be used against coronavirus SARS-CoV-2, strain hCoV-19/Russia/Vologda-171613-1208/2020.
1 cl, 1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
3-BENZYL-5-METHYL-6-(PHENYLTHIO)-[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-7(3H)-ONE, WHICH HAS ANTIVIRAL ACTIVITY AGAINST THE SARS-CoV2 CORONAVIRUS | 2022 |
|
RU2808622C1 |
AGENT FOR INHIBITION OF SARS-CoV-2 VIRUS STRAINS BASED ON (+)-USNIC ACID | 2023 |
|
RU2832905C1 |
OBTAINING A WATER-SOLUBLE 6-BROMO-1-METHYL-5-METHOXY-2-(1-PIPERIDINOMETHYL)-3-(2-DIETHYLAMINOETHOXY) CARBONYLINDOLE DIHYDROCHLORIDE COMPOUND | 2024 |
|
RU2835077C1 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
STRAIN OF HCOV-19/RUSSIA/OMSK-202118-1707/2020 OF SARS-COV-2 CORONAVIRUS, IMMUNOSORBENT CONTAINING PURIFIED WHOLE VIRION ANTIGEN OBTAINED ON BASIS OF SPECIFIED STRAIN AND ISA TEST SYSTEM FOR DETECTING ANTIBODIES OF CLASSES M, G AND A TO SARS CORONAVIRUS-COV-2 USING SPECIFIED IMMUNOSORBENT | 2021 |
|
RU2752862C1 |
HEAVY-CHAIN MONOCLONAL ANTIBODIES SPECIFICALLY BINDING TO S PROTEIN OF SARS-CoV-2 VIRUS, AND METHOD OF USING THEM FOR TREATMENT OF DISEASES CAUSED BY DIFFERENT VARIANTS OF SARS-CoV-2 VIRUS | 2024 |
|
RU2836313C1 |
SARS-CoV-2 CORONAVIRUS REPLICATION INHIBITOR BASED ON HUMIC SUBSTANCES | 2020 |
|
RU2752872C1 |
MEFLOQUINE AND COMBINATIONS THEREOF FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | 2020 |
|
RU2763024C1 |
METHOD OF PRODUCING OXYGEN-CONTAINING DERIVATIVE OF 6-HALOGENQUINOLINE FOR INHIBITING REPLICATION OF BETA-CORONAVIRUSES, INCLUDING SARS-CoV-2 | 2021 |
|
RU2827892C1 |
APPLICATION OF AN OXYGEN-CONTAINING DERIVATIVE OF 6-HALOQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2, AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2780245C1 |
Authors
Dates
2025-04-30—Published
2024-07-23—Filed